NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 12, 2021 $285.00 +40.55% $202.77 X 59.45% 1
Diamond Diamond Pro
Mar 12, 2021 $169.28 -16.52% $202.77 X 83.48% 0
JS JS Pro
Mar 4, 2021 $195.20 +23.47% $158.10 X 76.53% 0
Mar 4, 2021 Bullish $158.10 X 0
JS JS Pro
Feb 26, 2021 $234.86 +1.57% $231.23 X 98.43% 1
Feb 26, 2021 Bullish $231.23 X 1
JS JS Pro
Feb 18, 2021 $277.33 +4.54% $265.29 X 95.46% 0
chris kenmore chris kenmore @chriskenmore.139772
Feb 18, 2021 $265.00 -0.11% $265.29 X 99.89% 6
JS JS Pro
Feb 1, 2021 $208.09 -22.44% $268.30 X 77.56% 0
Evan Guthrie Evan Guthrie @EvanGuthrie.196838
Feb 1, 2021 $220.94 -17.65% $268.30 X 82.35% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE